Академический Документы
Профессиональный Документы
Культура Документы
INDEX
To aid users the index includes a reference to the supplement where the latest version of a text can be found.
For example: Acetone...............................................5.1-2875
means the monograph Acetone can be found on page 2875 of Supplement 5.1.
Note that where no reference for a supplement is made, the text can be found in the principal volume.
General Notices (1) apply to all monographs and other texts 3649
EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3651
Index EUROPEAN PHARMACOPOEIA 5.3
2.5.28. Water in gases............................................................... 136 2.7.6. Assay of diphtheria vaccine (adsorbed) ..................... 196
2.5.29. Sulphur dioxide ............................................................ 136 2.7.7. Assay of pertussis vaccine............................................. 197
2.5.2. Ester value ....................................................................... 127 2.7.8. Assay of tetanus vaccine (adsorbed)..................5.1-2791
2.5.30. Oxidising substances................................................... 137 2.7.9. Test for Fc function of immunoglobulin ................... 202
2.5.31. Ribose in polysaccharide vaccines............................ 137 2.7. Biological assays ................................................................ 187
2.5.32. Water: micro determination ...................................... 137 2.8.10. Solubility in alcohol of essential oils ........................216
2.5.33. Total protein.................................................................. 138 2.8.11. Assay of 1,8-cineole in essential oils .........................216
2.5.34. Acetic acid in synthetic peptides ...............................141 2.8.12. Determination of essential oils in vegetable
2.5.35. Nitrous oxide in gases..................................................141 drugs............................................................................................217
2.5.36. Anisidine value ............................................................. 142 2.8.13. Pesticide residues..........................................................218
2.5.3. Hydroxyl value ................................................................ 127 2.8.14. Determination of tannins in herbal drugs .............. 221
2.5.4. Iodine value ..................................................................... 127 2.8.15. Bitterness value ............................................................ 221
2.5.5. Peroxide value................................................................. 128 2.8.16. Dry residue of extracts................................................ 222
2.5.6. Saponification value ...................................................... 129 2.8.17. Loss on drying of extracts .......................................... 222
2.5.7. Unsaponifiable matter ................................................... 129 2.8.1. Ash insoluble in hydrochloric acid ............................. 215
2.5.8. Determination of primary aromatic 2.8.2. Foreign matter ................................................................ 215
amino-nitrogen ......................................................................... 129 2.8.3. Stomata and stomatal index ........................................ 215
2.5.9. Determination of nitrogen by sulphuric acid 2.8.4. Swelling index ................................................................. 215
digestion .................................................................................... 129 2.8.5. Water in essential oils.....................................................216
2.5. Assays ................................................................................... 127 2.8.6. Foreign esters in essential oils .....................................216
2.6.10. Histamine ....................................................................... 153 2.8.7. Fatty oils and resinified essential oils in essential
2.6.11. Depressor substances.................................................. 153 oils................................................................................................216
2.6.12. Microbiological examination of non-sterile products 2.8.8. Odour and taste of essential oils..................................216
(total viable aerobic count).................................................... 154 2.8.9. Residue on evaporation of essential oils....................216
2.6.13. Microbiological examination of non-sterile products 2.8. Methods in pharmacognosy ............................................ 215
(test for specified micro-organisms)..................................... 156 2.9.10. Ethanol content and alcoholimetric tables ............ 237
2.6.14. Bacterial endotoxins .....................................................161 2.9.11. Test for methanol and 2-propanol ...................5.3-3362
2.6.15. Prekallikrein activator................................................. 168 2.9.12. Sieve test ........................................................................ 239
2.6.16. Tests for extraneous agents in viral vaccines for 2.9.13. Limit test of particle size by microscopy................. 239
human use................................................................................. 169 2.9.14. Specific surface area by air permeability ................ 239
2.6.17. Test for anticomplementary activity of 2.9.15. Apparent volume .......................................................... 241
immunoglobulin....................................................................... 170 2.9.16. Flowability...................................................................... 242
2.6.18. Test for neurovirulence of live virus vaccines........ 172 2.9.17. Test for extractable volume of parenteral
2.6.19. Test for neurovirulence of poliomyelitis vaccine preparations.....................................................................5.3-3363
(oral) ........................................................................................... 172 2.9.18. Preparations for inhalation : aerodynamic assessment
2.6.1. Sterility ............................................................................. 145 of fine particles ............................................................... 5.2-3103
2.6.20. Anti-A and anti-B haemagglutinins 2.9.19. Particulate contamination : sub-visible particles... 253
(indirect method) ......................................................................174 2.9.1. Disintegration of tablets and capsules..............5.3-3351
2.6.21. Nucleic acid amplification techniques ......................174 2.9.20. Particulate contamination : visible particles.......... 255
2.6.22. Activated coagulation factors .................................... 177 2.9.22. Softening time determination of lipophilic
2.6.24. Avian viral vaccines : tests for extraneous agents in suppositories............................................................................. 256
seed lots ..................................................................................... 177 2.9.23. Pycnometric density of solids.................................... 257
2.6.25. Avian live virus vaccines : tests for extraneous agents 2.9.24. Resistance to rupture of suppositories and
in batches of finished product .....................................5.3-3345 pessaries .................................................................................... 258
2.6.26. Test for anti-D antibodies in human immunoglobulin 2.9.25. Dissolution test for medicated chewing
for intravenous administration ....................................5.3-3348 gums .................................................................................. 5.2-3116
2.6.2. Mycobacteria ................................................................... 149 2.9.26. Specific surface area by gas adsorption......... 5.1-2811
2.6.7. Mycoplasmas.................................................................... 149 2.9.27. Uniformity of mass of delivered doses from multidose
2.6.8. Pyrogens........................................................................... 152 containers.................................................................................. 263
2.6.9. Abnormal toxicity ........................................................... 153 2.9.28. Test for deliverable mass or volume of liquid and
2.6. Biological tests ................................................................... 145 semi-solid preparations........................................................... 263
2.7.10. Assay of human coagulation factor VII ................... 203 2.9.2. Disintegration of suppositories and pessaries ......... 227
2.7.11. Assay of human coagulation factor IX ..................... 204 2.9.36. Powder flow..........................................................5.3-3363
2.7.12. Assay of heparin in coagulation factors .................. 204 2.9.37. Optical microscopy..............................................5.3-3366
2.7.13. Assay of human anti-D immunoglobulin................. 205 2.9.38. Particle-size distribution estimation by analytical
2.7.14. Assay of hepatitis A vaccine ..............................5.1-2795 sieving ...............................................................................5.3-3368
2.7.15. Assay of hepatitis B vaccine (rDNA)......................... 207 2.9.3. Dissolution test for solid dosage forms ............5.3-3353
2.7.16. Assay of pertussis vaccine (acellular)....................... 208 2.9.40. Uniformity of dosage units................................5.3-3370
2.7.17. Assay of human antithrombin III .............................. 209 2.9.42. Dissolution test for lipophilic solid dosage
2.7.18. Assay of human coagulation factor II ...................... 209 forms..................................................................................5.3-3373
2.7.19. Assay of human coagulation factor X .......................210 2.9.4. Dissolution test for transdermal patches .................. 231
2.7.1. Immunochemical methods ........................................... 187 2.9.5. Uniformity of mass of single-dose preparations....... 233
2.7.20. In vivo assay of poliomyelitis vaccine 2.9.6. Uniformity of content of single-dose preparations.. 234
(inactivated) ...............................................................................210 2.9.7. Friability of uncoated tablets .............................. 5.2-3103
2.7.21. Assay of human von Willebrand factor.....................211 2.9.8. Resistance to crushing of tablets................................ 235
2.7.22. Assay of human coagulation factor XI..................... 212 2.9.9. Measurement of consistency by penetrometry ........ 235
2.7.2. Microbiological assay of antibiotics............................ 188 2.9. Pharmaceutical technical procedures ........................... 225
2.7.4. Assay of human coagulation factor VIII .................... 194 2-Ethylhexanoic acid (2.4.28.) ................................................. 120
2.7.5. Assay of heparin.............................................................. 195 2-Propanol and methanol, test for (2.9.11.).................5.3-3362
3.1.10. Materials based on non-plasticised poly(vinyl chloride) 5.1.2. Biological indicators of sterilisation........................... 447
for containers for non-injectable, aqueous solutions ...... 289 5.1.3. Efficacy of antimicrobial preservation ....................... 447
3.1.11. Materials based on non-plasticised poly(vinyl 5.1.4. Microbiological quality of pharmaceutical
chloride) for containers for dry dosage forms for oral preparations.............................................................................. 449
administration .......................................................................... 291 5.1.5. Application of the F0 concept to steam sterilisation of
3.1.1.1. Materials based on plasticised poly(vinyl chloride) for aqueous preparations ....................................................5.1-2821
containers for human blood and blood components....... 269 5.1. General texts on sterility .................................................. 445
3.1.1.2. Materials based on plasticised poly(vinyl chloride) 5.2.1. Terminology used in monographs on vaccines ....... 453
for tubing used in sets for the transfusion of blood and 5.2.2. Chicken flocks free from specified pathogens for the
blood components ................................................................... 272 production and quality control of vaccines...............5.1-2825
3.1.13. Plastic additives ............................................................ 293 5.2.3. Cell substrates for the production of vaccines for
3.1.14. Materials based on plasticised poly(vinyl chloride) human use................................................................................. 455
for containers for aqueous solutions for intravenous 5.2.4. Cell cultures for the production of veterinary
infusion ...................................................................................... 296 vaccines...................................................................................... 458
3.1.15. Polyethylene terephthalate for containers for 5.2.5. Substances of animal origin for the production of
preparations not for parenteral use..................................... 298 veterinary vaccines.................................................................. 460
3.1.1. Materials for containers for human blood and blood 5.2.6. Evaluation of safety of veterinary vaccines and
components............................................................................... 269 immunosera ....................................................................5.1-2827
3.1.3. Polyolefines...................................................................... 274 5.2.7. Evaluation of efficacy of veterinary vaccines and
3.1.4. Polyethylene without additives for containers immunosera .....................................................................5.1-2829
for parenteral preparations and for ophthalmic 5.2.8. Minimising the risk of transmitting animal spongiform
preparations.............................................................................. 278 encephalopathy agents via human and veterinary medicinal
3.1.5. Polyethylene with additives for containers products ..................................................................................... 463
for parenteral preparations and for ophthalmic 5.2.9. Evaluation of safety of each batch of veterinary
preparations.............................................................................. 279 vaccines and immunosera.............................................5.1-2830
3.1.6. Polypropylene for containers and closures for 5.2. General texts on vaccines................................................. 453
parenteral preparations and ophthalmic preparations ... 282 5.3. Statistical analysis of results of biological assays and
3.1.7. Poly(ethylene - vinyl acetate) for containers and tubing tests............................................................................................. 475
for total parenteral nutrition preparations ........................ 285 5.4. Residual solvents ............................................................... 507
3.1.8. Silicone oil used as a lubricant ................................... 287 5.5. Alcoholimetric tables .........................................................519
3.1.9. Silicone elastomer for closures and tubing .............. 288 5.6. Assay of interferons..................................................5.3-3381
3.1. Materials used for the manufacture of containers ..... 269 5.7. Table of physical characteristics of radionuclides
3.2.1. Glass containers for pharmaceutical use .................. 303 mentioned in the European Pharmacopoeia..................... 539
3.2.2.1. Plastic containers for aqueous solutions for 5.8. Pharmacopoeial harmonisation ..................................... 551
parenteral infusion .................................................................. 309 5.9. Polymorphism..................................................................... 555
3.2.2. Plastic containers and closures for pharmaceutical
use............................................................................................... 308 A
3.2.3. Sterile plastic containers for human blood and blood Abbreviations and symbols (1.5.).................................................9
components............................................................................... 309 Abnormal toxicity (2.6.9.)......................................................... 153
3.2.4. Empty sterile containers of plasticised poly(vinyl Absinthii herba ........................................................................ 2710
chloride) for human blood and blood components...........311 Absorption spectrophotometry, infrared (2.2.24.)................ 37
3.2.5. Sterile containers of plasticised poly (vinyl chloride) Absorption spectrophotometry, ultraviolet and visible
for human blood containing anticoagulant solution....... 312 (2.2.25.) .............................................................................5.2-3089
3.2.6. Sets for the transfusion of blood and blood Acacia............................................................................................ 905
components................................................................................313 Acaciae gummi .......................................................................... 905
3.2.8. Sterile single-use plastic syringes ................................314 Acaciae gummi dispersione desiccatum............................. 905
3.2.9. Rubber closures for containers for aqueous parenteral Acacia, spray-dried ..................................................................... 905
preparations, for powders and for freeze-dried powders ..316 Acamprosate calcium ................................................................ 906
3.2. Containers ........................................................................... 303 Acamprosatum calcicum......................................................... 906
4.1.1. Reagents ........................................................................... 321 Acarbose..............................................................................5.1-2873
4.1.1. Reagents .................................................................. 5.1-2817 Acarbosum .........................................................................5.1-2873
4.1.1. Reagents ..................................................................5.2-3123 Acebutolol hydrochloride......................................................... 907
4.1.1. Reagents ..................................................................5.3-3377 Acebutololi hydrochloridum .................................................. 907
4.1.2. Standard solutions for limit tests................................ 426 Aceclofenac.................................................................................. 909
4.1.2. Standard solutions for limit tests....................... 5.1-2818 Aceclofenacum........................................................................... 909
4.1.3. Buffer solutions .............................................................. 430 Acesulfame potassium .....................................................5.3-3435
4.1.3. Buffer solutions .....................................................5.3-3378 Acesulfamum kalicum ....................................................5.3-3435
4.1. Reagents, standard solutions, buffer solutions ........... 321 Acetazolamide............................................................................. 912
4.2.1. Primary standards for volumetric solutions............. 435 Acetazolamidum........................................................................ 912
4.2.1. Primary standards for volumetric solutions....5.3-3378 Acetic acid, glacial ......................................................................913
4.2.2. Volumetric solutions...................................................... 435 Acetic acid in synthetic peptides (2.5.34.) .............................141
4.2.2. Volumetric solutions.............................................5.3-3378 Acetone................................................................................5.1-2875
4.2. Volumetric analysis............................................................ 435 Acetonum ...........................................................................5.1-2875
4-Aminobenzoic acid ................................................................. 973 Acetylcholine chloride ...............................................................914
4. Reagents.................................................................................. 321 Acetylcholini chloridum...........................................................914
5.10. Control of impurities in substances for pharmaceutical Acetylcysteine ..............................................................................915
use............................................................................................... 559 Acetylcysteinum .........................................................................915
5.11. Characters section in monographs .............................. 565 Acetylsalicylic acid ......................................................................917
5.1.1. Methods of preparation of sterile products .............. 445 Acetyltryptophan, N- ..................................................................918
General Notices (1) apply to all monographs and other texts 3653
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3655
Index EUROPEAN PHARMACOPOEIA 5.3
Antithrombin III, human, assay of (2.7.17.) .......................... 209 Assay of pertussis vaccine (2.7.7.)........................................... 197
Antithrombinum III humanum densatum ....................... 1733 Assay of pertussis vaccine (acellular) (2.7.16.) .................... 208
Anti-T lymphocyte immunoglobulin for human use, Assay of tetanus vaccine (adsorbed) (2.7.8.) ...............5.1-2791
animal....................................................................................... 1010 Assays (2.5.)................................................................................. 127
Apis mellifera ad praeparationes homoeopathicas.......... 898 Astemizole ................................................................................. 1030
Apomorphine hydrochloride ..................................................1014 Astemizolum............................................................................. 1030
Apomorphini hydrochloridum .............................................1014 Atenolol...................................................................................... 1032
Apparatus (2.1.) .............................................................................17 Atenololum................................................................................ 1032
Apparent volume (2.9.15.)........................................................ 241 Atomic absorption spectrometry (2.2.23.) .............................. 36
Application of the F0 concept to steam sterilisation of Atomic emission spectrometry (2.2.22.).................................. 35
aqueous preparations (5.1.5.).......................................5.1-2821 Atracurii besilas................................................................ 5.2-3170
Aprotinin .................................................................................... 1015 Atracurium besilate .......................................................... 5.2-3170
Aprotinin concentrated solution........................................... 1016 Atropine ..................................................................................... 1033
Aprotinini solutio concentrata ............................................ 1016 Atropine sulphate..................................................................... 1035
Aprotininum ............................................................................. 1015 Atropini sulfas.......................................................................... 1035
Aqua ad dilutionem solutionium concentratarum ad Atropinum ................................................................................. 1033
haemodialysim ...................................................................... 1699 Aujeszky’s disease vaccine (inactivated) for pigs................ 715
Aqua ad iniectabilia ...............................................................2692 Aujeszky’s disease vaccine (live) for pigs for parenteral
Aquae (15O) solutio iniectabilis.............................................. 868 administration, freeze-dried....................................................717
Aquae tritiatae (3H) solutio iniectabilis............................... 867 Aurantii amari epicarpii et mesocarpii tinctura ............ 1110
Aqua purificata........................................................................2697 Aurantii amari epicarpium et mesocarpium................... 1110
Aqua valde purificata.............................................................2695 Aurantii amari flos ..................................................................1111
Arachidis oleum hydrogenatum.......................................... 1018 Aurantii dulcis aetheroleum.................................................2526
Arachidis oleum raffinatum ................................................. 1018 Auricularia.........................................................................5.2-3137
Arachis oil, hydrogenated ...................................................... 1018 Avian infectious bronchitis vaccine (inactivated)................ 718
Arachis oil, refined................................................................... 1018 Avian infectious bronchitis vaccine (live) ............................. 720
Argenti nitras ........................................................................... 2412 Avian infectious bursal disease vaccine (inactivated) ....... 722
Argentum colloidale ad usum externum ...................5.3-3613 Avian infectious bursal disease vaccine (live) ...................... 723
Arginine...................................................................................... 1019 Avian infectious encephalomyelitis vaccine (live) ............... 725
Arginine aspartate ................................................................... 1020 Avian infectious laryngotracheitis vaccine (live)................. 727
Arginine hydrochloride........................................................... 1021 Avian live virus vaccines : tests for extraneous agents in
Arginini aspartas .................................................................... 1020 batches of finished product (2.6.25.)..........................5.3-3345
Arginini hydrochloridum...................................................... 1021 Avian paramyxovirus 3 vaccine (inactivated)....................... 728
Argininum................................................................................. 1019 Avian viral tenosynovitis vaccine (live).................................. 729
Arnicae flos............................................................................... 1022 Avian viral vaccines : tests for extraneous agents in seed lots
Arnicae tinctura ...............................................................5.1-2877 (2.6.24.) ...................................................................................... 177
Arnica flower............................................................................. 1022 Azaperone for veterinary use ................................................ 1036
Arnica tincture...................................................................5.1-2877 Azaperonum ad usum veterinarium.................................. 1036
Arsenic (2.4.2.)............................................................................ 103 Azathioprine.............................................................................. 1037
Arsenii trioxidum ad praeparationes homoeopathicas .. 895 Azathioprinum......................................................................... 1037
Arsenious trioxide for homoeopathic preparations............ 895 Azelastine hydrochloride........................................................ 1037
Articaine hydrochloride.......................................................... 1023 Azelastini hydrochloridum................................................... 1037
Articaini hydrochloridum..................................................... 1023 Azithromycin......................................................................5.3-3442
Ascorbic acid ............................................................................. 1025 Azithromycinum...............................................................5.3-3442
Ascorbylis palmitas................................................................. 1026
Ascorbyl palmitate ................................................................... 1026 B
Ash insoluble in hydrochloric acid (2.8.1.)........................... 215 Bacampicillin hydrochloride.................................................. 1043
Ash leaf....................................................................................... 1026 Bacampicillini hydrochloridum.......................................... 1043
Asparagine monohydrate ....................................................... 1027 Bacitracin................................................................................... 1045
Asparaginum monohydricum.............................................. 1027 Bacitracinum............................................................................ 1045
Aspartame.................................................................................. 1028 Bacitracinum zincum ............................................................ 1047
Aspartamum ............................................................................. 1028 Bacitracin zinc .......................................................................... 1047
Aspartic acid.............................................................................. 1029 Baclofen ..................................................................................... 1050
Assay of 1,8-cineole in essential oils (2.8.11.) .......................216 Baclofenum............................................................................... 1050
Assay of diphtheria vaccine (adsorbed) (2.7.6.) ................... 196 Bacterial endotoxins (2.6.14.)...................................................161
Assay of heparin (2.7.5.) ........................................................... 195 Ballotae nigrae herba ............................................................ 1113
Assay of heparin in coagulation factors (2.7.12.)................ 204 Balsamum peruvianum......................................................... 2215
Assay of hepatitis A vaccine (2.7.14.) ............................5.1-2795 Balsamum tolutanum ............................................................2603
Assay of hepatitis B vaccine (rDNA) (2.7.15.) ...................... 207 Bambuterol hydrochloride..................................................... 1051
Assay of human anti-D immunoglobulin (2.7.13.)............... 205 Bambuteroli hydrochloridum .............................................. 1051
Assay of human antithrombin III (2.7.17.) ............................ 209 Barbados aloes ........................................................................... 947
Assay of human coagulation factor II (2.7.18.).................... 209 Barbital....................................................................................... 1052
Assay of human coagulation factor IX (2.7.11.)................... 204 Barbitalum ................................................................................ 1052
Assay of human coagulation factor VII (2.7.10.) ................. 203 Barii chloridum dihydricum ad praeparationes
Assay of human coagulation factor VIII (2.7.4.).................. 194 homoeopathicas ............................................................. 5.2-3161
Assay of human coagulation factor X (2.7.19.) .....................210 Barii sulfas.........................................................................5.3-3447
Assay of human coagulation factor XI (2.7.22.) .................. 212 Barium chloride dihydrate for homoeopathic
Assay of human von Willebrand factor (2.7.21.) ..................211 preparations..................................................................... 5.2-3161
Assay of interferons (5.6.)................................................5.3-3381 Barium sulphate................................................................5.3-3447
General Notices (1) apply to all monographs and other texts 3657
Index EUROPEAN PHARMACOPOEIA 5.3
Bovine infectious rhinotracheitis vaccine (live), Calcii chloridum dihydricum .............................................. 1152
freeze-dried................................................................................ 768 Calcii chloridum hexahydricum ......................................... 1153
Bovine insulin........................................................................... 1797 Calcii dobesilas monohydricum.......................................... 1153
Bovine leptospirosis vaccine (inactivated)............................ 730 Calcii folinas ............................................................................ 1154
Bovine parainfluenza virus vaccine (live), freeze-dried ..... 732 Calcii glucoheptonas.............................................................. 1156
Bovine respiratory syncytial virus vaccine (live), Calcii gluconas ........................................................................ 1157
freeze-dried................................................................................ 733 Calcii gluconas ad iniectabile ............................................. 1158
Bovine viral diarrhoea vaccine (inactivated)........................ 734 Calcii glycerophosphas.......................................................... 1159
Bromazepam ............................................................................. 1119 Calcii hydrogenophosphas anhydricus............................. 1160
Bromazepamum...................................................................... 1119 Calcii hydrogenophosphas dihydricus.............................. 1160
Bromhexine hydrochloride .................................................... 1120 Calcii hydroxidum .................................................................. 1161
Bromhexini hydrochloridum ............................................... 1120 Calcii iodidum tetrahydricum ad praeparationes
Bromocriptine mesilate .......................................................... 1121 homoeopathicas ............................................................. 5.2-3162
Bromocriptini mesilas ........................................................... 1121 Calcii lactas anhydricus.................................................5.1-2894
Bromperidol .............................................................................. 1124 Calcii lactas monohydricus...........................................5.1-2895
Bromperidol decanoate .......................................................... 1125 Calcii lactas pentahydricus ...........................................5.1-2896
Bromperidoli decanoas ......................................................... 1125 Calcii lactas trihydricus .................................................5.1-2897
Bromperidolum ....................................................................... 1124 Calcii laevulinas dihydricum............................................... 1165
Brompheniramine maleate..................................................... 1127 Calcii levofolinas pentahydricus ........................................ 1163
Brompheniramini maleas .................................................... 1127 Calcii pantothenas.................................................................. 1166
Brucellosis vaccine (live) (Brucella melitensis Rev. 1 strain), Calcii stearas ............................................................................ 1167
freeze-dried, for veterinary use ...................................5.1-2859 Calcii sulfas dihydricus ......................................................... 1169
Buccal tablets and sublingual tablets.................................... 613 Calcipotriol, anhydrous ...................................................5.3-3460
Buckwheat herb ................................................................ 5.2-3180 Calcipotriol monohydrate ...............................................5.3-3462
Budesonide................................................................................ 1128 Calcipotriolum anhydricum..........................................5.3-3460
Budesonidum ........................................................................... 1128 Calcipotriolum monohydricum....................................5.3-3462
Bufexamac ................................................................................. 1130 Calcitonin (salmon)...........................................................5.3-3465
Bufexamacum .......................................................................... 1130 Calcitoninum salmonis ..................................................5.3-3465
Buffer solutions (4.1.3.) ............................................................ 430 Calcitriol..................................................................................... 1149
Buffer solutions (4.1.3.) ...................................................5.3-3378 Calcitriolum.............................................................................. 1149
Buflomedil hydrochloride ...................................................... 1131 Calcium (2.4.3.)........................................................................... 103
Buflomedili hydrochloridum ............................................... 1131 Calcium acetate .................................................................5.1-2893
Bumetanide ............................................................................... 1132 Calcium ascorbate.................................................................... 1150
Bumetanidum .......................................................................... 1132 Calcium carbonate ............................................................5.1-2894
Bupivacaine hydrochloride .................................................... 1133 Calcium carboxymethylcellulose .......................................... 1188
Bupivacaini hydrochloridum............................................... 1133 Calcium chloride dihydrate.................................................... 1152
Buprenorphine ......................................................................... 1135 Calcium chloride hexahydrate .............................................. 1153
Buprenorphine hydrochloride .............................................. 1136 Calcium dobesilate monohydrate ......................................... 1153
Buprenorphini hydrochloridum ......................................... 1136 Calcium folinate ....................................................................... 1154
Buprenorphinum ................................................................... 1135 Calcium glucoheptonate......................................................... 1156
Buserelin.................................................................................... 1137 Calcium gluconate ................................................................... 1157
Buserelinum ............................................................................. 1137 Calcium gluconate for injection............................................ 1158
Buspirone hydrochloride.................................................5.3-3452 Calcium glycerophosphate..................................................... 1159
Buspironi hydrochloridum............................................5.3-3452 Calcium hydrogen phosphate, anhydrous .......................... 1160
Busulfan..................................................................................... 1138 Calcium hydrogen phosphate dihydrate ............................. 1160
Busulfanum .............................................................................. 1138 Calcium hydroxide ................................................................... 1161
Butcher’s broom................................................................5.3-3454 Calcium in adsorbed vaccines (2.5.14.) ..................................131
Butylhydroxyanisole.................................................................1141 Calcium iodide tetrahydrate for homoeopathic
Butylhydroxyanisolum ...........................................................1141 preparations..................................................................... 5.2-3162
Butylhydroxytoluene................................................................1141 Calcium lactate, anhydrous ............................................5.1-2894
Butylhydroxytoluenum...........................................................1141 Calcium lactate monohydrate ........................................5.1-2895
Butylis parahydroxybenzoas................................................ 1140 Calcium lactate pentahydrate ........................................5.1-2896
Butyl parahydroxybenzoate................................................... 1140 Calcium lactate trihydrate...............................................5.1-2897
Calcium levofolinate pentahydrate ...................................... 1163
C Calcium levulinate dihydrate................................................. 1165
Cabergoline ........................................................................5.3-3459 Calcium pantothenate............................................................. 1166
Cabergolinum ...................................................................5.3-3459 Calcium phosphate .................................................................. 1167
Cachets ................................................................................5.2-3136 Calcium stearate....................................................................... 1167
Cadmii sulfas hydricus Calcium sulphate dihydrate................................................... 1169
ad praeparationes homoeopathicas..........................5.3-3429 Calendulae flos ........................................................................ 1169
Cadmium sulphate hydrate for homoeopathic prepara- Calendula flower ...................................................................... 1169
tions ...................................................................................5.3-3429 Calf coronavirus diarrhoea vaccine (inactivated)................ 736
Caffeine ...................................................................................... 1145 Calf rotavirus diarrhoea vaccine (inactivated)..................... 737
Caffeine monohydrate............................................................. 1146 Calicivirosis vaccine (inactivated), feline............................... 757
Calcifediol .................................................................................. 1147 Calicivirosis vaccine (live), feline, freeze-dried..................... 758
Calcifediolum ........................................................................... 1147 Camphora racemica ............................................................... 1172
Calcii acetas ......................................................................5.1-2893 Camphor, D- ............................................................................... 1170
Calcii ascorbas......................................................................... 1150 Camphor, racemic .................................................................... 1172
Calcii carbonas .................................................................5.1-2894 Canine adenovirus vaccine (inactivated) .............................. 738
General Notices (1) apply to all monographs and other texts 3659
Index EUROPEAN PHARMACOPOEIA 5.3
Cinnamomi cortex ..................................................................1295 Clostridium perfringens beta antitoxin for veterinary use
Cinnamomi corticis tinctura................................................1297 ............................................................................................5.1-2866
Cinnamomi zeylanici folii aetheroleum...........................1296 Clostridium perfringens epsilon antitoxin for veterinary use
Cinnamomi zeylanicii corticis aetheroleum ...................1295 ............................................................................................5.1-2867
Cinnamon ..................................................................................1295 Clostridium perfringens vaccine for veterinary use ........... 747
Cinnamon bark oil, Ceylon ....................................................1295 Clostridium septicum vaccine for veterinary use................ 749
Cinnamon leaf oil, Ceylon ......................................................1296 Closures and containers for parenteral preparations and
Cinnamon tincture...................................................................1297 ophthalmic preparations, polypropylene for (3.1.6.)........ 282
Cinnarizine ................................................................................1297 Closures and containers for pharmaceutical use, plastic
Cinnarizinum ..........................................................................1297 (3.2.2.) ........................................................................................ 308
Ciprofibrate ...............................................................................1299 Closures and tubing, silicone elastomer for (3.1.9.)........... 288
Ciprofibratum...........................................................................1299 Closures for containers for aqueous parenteral preparations,
Ciprofloxacin.............................................................................1300 for powders and for freeze-dried powders, rubber
Ciprofloxacin hydrochloride..................................................1302 (3.2.9.) .........................................................................................316
Ciprofloxacini hydrochloridum ..........................................1302 Clotrimazole..............................................................................1333
Ciprofloxacinum .....................................................................1300 Clotrimazolum .........................................................................1333
Circular dichroism (2.2.41.) ....................................................... 63 Clove ...........................................................................................1334
Cisapride monohydrate...........................................................1303 Clove oil .....................................................................................1335
Cisapride tartrate .....................................................................1304 Cloxacillin sodium....................................................................1335
Cisapridi tartras ......................................................................1304 Cloxacillinum natricum ........................................................1335
Cisapridum monohydricum.................................................1303 Clozapine ...................................................................................1337
Cisplatin .....................................................................................1306 Clozapinum ..............................................................................1337
Cisplatinum ..............................................................................1306 Coagulation factor II, assay of (2.7.18.)................................. 209
Citric acid, anhydrous .............................................................1306 Coagulation factor IX, assay of (2.7.11.)................................ 204
Citric acid monohydrate .........................................................1307 Coagulation factor IX, human............................................... 1738
Citronellae aetheroleum........................................................1308 Coagulation factors, activated (2.6.22.)................................. 177
Citronella oil..............................................................................1308 Coagulation factors, assay of heparin (2.7.12.) ................... 204
Clarithromycin...................................................................5.1-2900 Coagulation factor VII, assay of (2.7.10.).............................. 203
Clarithromycinum ...........................................................5.1-2900 Coagulation factor VII, human ............................................. 1734
Clarity and degree of opalescence of liquids (2.2.1.)............ 23 Coagulation factor VIII, assay of (2.7.4.)............................... 194
Clary sage oil............................................................................. 1311 Coagulation factor VIII, human.....................................5.3-3513
Clazuril for veterinary use ..................................................... 1312 Coagulation factor VIII (rDNA), human ............................. 1737
Clazurilum ad usum veterinarium..................................... 1312 Coagulation factor X, assay of (2.7.19.)..................................210
Clebopride malate.................................................................... 1314 Coagulation factor XI, assay of (2.7.22.) ............................... 212
Clebopridi malas ..................................................................... 1314 Coagulation factor XI, human............................................... 1739
Clemastine fumarate ............................................................... 1315 Coated granules ................................................................ 5.2-3141
Clemastini fumaras ................................................................ 1315 Coated tablets .................................................................... 5.2-3151
Clenbuterol hydrochloride..............................................5.1-2902 Cocaine hydrochloride............................................................1338
Clenbuteroli hydrochloridum .......................................5.1-2902 Cocaini hydrochloridum.......................................................1338
Clindamycin hydrochloride.................................................... 1318 Cocois oleum raffinatum.......................................................1339
Clindamycini hydrochloridum............................................ 1318 Coconut oil, refined.................................................................1339
Clindamycini phosphas......................................................... 1319 Cocoyl caprylocaprate...................................................... 5.2-3189
Clindamycin phosphate .......................................................... 1319 Cocoylis caprylocapras................................................... 5.2-3189
Clioquinol .................................................................................. 1321 Codeine ...............................................................................5.1-2905
Clioquinolum ........................................................................... 1321 Codeine hydrochloride dihydrate..................................5.1-2906
Clobazam ...................................................................................1322 Codeine phosphate hemihydrate...................................5.1-2908
Clobazamum ............................................................................1322 Codeine phosphate sesquihydrate ................................5.1-2909
Clobetasone butyrate ..............................................................1323 Codeini hydrochloridum dihydricum.........................5.1-2906
Clobetasoni butyras ................................................................1323 Codeini phosphas hemihydricus .................................5.1-2908
Clofazimine................................................................................1324 Codeini phosphas sesquihydricus ...............................5.1-2909
Clofaziminum ..........................................................................1324 Codeinum...........................................................................5.1-2905
Clofibrate ...................................................................................1325 Codergocrine mesilate ............................................................1347
Clofibratum...............................................................................1325 Codergocrini mesilas .............................................................1347
Clomifene citrate ......................................................................1326 Cod-liver oil (type A)................................................................1348
Clomifeni citras .......................................................................1326 Cod-liver oil (type B)................................................................1352
Clomipramine hydrochloride.................................................1328 Coffeinum.................................................................................. 1145
Clomipramini hydrochloridum ...........................................1328 Coffeinum monohydricum ................................................... 1146
Clonazepam...............................................................................1330 Cola .............................................................................................1356
Clonazepamum .......................................................................1330 Colae semen .............................................................................1356
Clonidine hydrochloride......................................................... 1331 Colchicine ..................................................................................1357
Clonidini hydrochloridum.................................................... 1331 Colchicinum .............................................................................1357
Closantel sodium dihydrate for veterinary use ..........5.1-2903 Colestyramine ...........................................................................1359
Closantelum natricum dihydricum Colestyraminum ......................................................................1359
ad usum veterinarium..................................................5.1-2903 Colibacillosis vaccine (inactivated), neonatal piglet........... 776
Clostridium botulinum vaccine for veterinary use ............. 745 Colibacillosis vaccine (inactivated), neonatal ruminant .... 778
Clostridium chauvoei vaccine for veterinary use................ 745 Colistimethate sodium ............................................................1360
Clostridium novyi alpha antitoxin for veterinary use ........5.1- Colistimethatum natricum ...................................................1360
2865 Colistini sulfas ..................................................................5.3-3480
Clostridium novyi (type B) vaccine for veterinary use....... 746 Colistin sulphate ...............................................................5.3-3480
General Notices (1) apply to all monographs and other texts 3661
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3663
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3665
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3667
Index EUROPEAN PHARMACOPOEIA 5.3
Haemophilus type b conjugate vaccine................................. 662 Hexosamines in polysaccharide vaccines (2.5.20.) ............. 132
Halofantrine hydrochloride ................................................... 1705 Hexylresorcinol......................................................................... 1723
Halofantrini hydrochloridum .............................................. 1705 Hexylresorcinolum ................................................................. 1723
Haloperidol................................................................................ 1706 Hibisci sabdariffae flos .......................................................... 2376
Haloperidol decanoate............................................................ 1708 Highly purified water ..............................................................2695
Haloperidoli decanoas........................................................... 1708 Histamine (2.6.10.)..................................................................... 153
Haloperidolum......................................................................... 1706 Histamine dihydrochloride .................................................... 1724
Halothane .................................................................................. 1709 Histamine phosphate .............................................................. 1725
Halothanum.............................................................................. 1709 Histamini dihydrochloridum ............................................... 1724
Hamamelidis folium............................................................... 1711 Histamini phosphas................................................................ 1725
Hamamelis leaf ......................................................................... 1711 Histidine..............................................................................5.1-2945
Hard capsules.....................................................................5.2-3135 Histidine hydrochloride monohydrate ................................ 1727
Hard fat ...................................................................................... 1711 Histidini hydrochloridum monohydricum....................... 1727
Hard paraffin............................................................................. 2186 Histidinum .........................................................................5.1-2945
Harpagophyti radix ................................................................ 1401 Homatropine hydrobromide .................................................. 1728
Hawthorn berries ..................................................................... 1712 Homatropine methylbromide ................................................ 1729
Hawthorn leaf and flower ...................................................... 1713 Homatropini hydrobromidum ............................................. 1728
Hawthorn leaf and flower dry extract ................................. 1714 Homatropini methylbromidum ........................................... 1729
Hawthorn leaf and flower liquid extract, quantified.. 5.3-3511 Homeopathic preparations, oriental cashew for........5.3-3430
Heavy bismuth subnitrate ...................................................... 1107 Homoeopathic preparations .................................................... 893
Heavy kaolin.............................................................................. 1869 Homoeopathic preparations, arsenious trioxide for .......... 895
Heavy magnesium carbonate .........................................5.3-3547 Homoeopathic preparations, calcium iodide tetrahydrate
Heavy magnesium oxide......................................................... 1958 for ....................................................................................... 5.2-3162
Heavy metals (2.4.8.) ................................................................. 104 Homoeopathic preparations, common stinging nettle
Heavy metals in herbal drugs and fatty oils (2.4.27.)..........119 for .......................................................................................5.3-3429
Hederae folium .................................................................5.1-2954 Homoeopathic preparations, copper acetate monohydrate
Hedera helix ad praeparationes homoeopathicas... 5.2-3163 for ....................................................................................... 5.2-3162
Hedera helix for homoeopathic preparations............. 5.2-3163 Homoeopathic preparations, copper for............................... 896
Helianthi annui oleum raffinatum.....................................2524 Homoeopathic preparations, garlic for ................................. 897
Heparina massae molecularis minoris ..............................1717 Homoeopathic preparations, hedera helix for............ 5.2-3163
Heparin, assay of (2.7.5.) .......................................................... 195 Homoeopathic preparations, herbal drugs for ........... 5.2-3161
Heparin calcium ....................................................................... 1715 Homoeopathic preparations, honey bee for......................... 898
Heparin in coagulation factors, assay of (2.7.12.)............... 204 Homoeopathic preparations, hyoscyamus for ............ 5.2-3164
Heparins, low-molecular-mass ................................................1717 Homoeopathic preparations, hypericum for ........................ 898
Heparin sodium........................................................................ 1716 Homoeopathic preparations, iron for .................................... 899
Heparinum calcicum ............................................................. 1715 Homoeopathic preparations, mother tinctures for............. 894
Heparinum natricum............................................................. 1716 Homoeopathic preparations, saffron for............................... 900
Hepatitis A immunoglobulin, human ...................................1741 Honey ..................................................................................5.1-2946
Hepatitis A (inactivated) and hepatitis B (rDNA) vaccine Honey bee for homoeopathic preparations.......................... 898
(adsorbed).................................................................................. 664 Hop strobile............................................................................... 1730
Hepatitis A vaccine, assay of (2.7.14.)...........................5.1-2795 Human albumin injection, iodinated (125I)............................ 827
Hepatitis A vaccine (inactivated, adsorbed) ......................... 665 Human albumin solution ................................................ 5.3-3511
Hepatitis A vaccine (inactivated, virosome) ......................... 667 Human anti-D immunoglobulin ............................................ 1732
Hepatitis B immunoglobulin for intravenous administration, Human anti-D immunoglobulin, assay of (2.7.13.).............. 205
human .......................................................................................1741 Human anti-D immunoglobulin for intravenous
Hepatitis B immunoglobulin, human ...................................1741 administration ........................................................................ 1733
Hepatitis B (rDNA), diphtheria and tetanus vaccine Human antithrombin III, assay of (2.7.17.)........................... 209
(adsorbed).................................................................................. 641 Human antithrombin III concentrate .................................. 1733
Hepatitis B (rDNA), diphtheria, tetanus and pertussis Human coagulation factor II, assay of (2.7.18.)................... 209
(acellular, component) vaccine (adsorbed) ........................ 647 Human coagulation factor IX................................................ 1738
Hepatitis B vaccine (rDNA)...................................................... 670 Human coagulation factor IX, assay of (2.7.11.).................. 204
Hepatitis B vaccine (rDNA), assay of (2.7.15.) ..................... 207 Human coagulation factor VII .............................................. 1734
Hepatitis C virus (HCV), validation of nucleic acid Human coagulation factor VII, assay of (2.7.10.)................ 203
amplification techniques for the detection of HCV RNA in Human coagulation factor VIII......................................5.3-3513
plasma pools : Guidelines........................................................176 Human coagulation factor VIII, assay of (2.7.4.)................. 194
Heptaminol hydrochloride..................................................... 1719 Human coagulation factor VIII (rDNA)............................... 1737
Heptaminoli hydrochloridum .............................................. 1719 Human coagulation factor X, assay of (2.7.19.) ....................210
Herbal drug preparations......................................................... 572 Human coagulation factor XI................................................ 1739
Herbal drugs ............................................................................... 572 Human coagulation factor XI, assay of (2.7.22.) ................. 212
Herbal drugs and fatty oils, heavy metals in (2.4.27.).........119 Human fibrinogen.................................................................... 1740
Herbal drugs, determination of tannins (2.8.14.) ............... 221 Human hepatitis A immunoglobulin ....................................1741
Herbal drugs for homoeopathic preparations ............ 5.2-3161 Human hepatitis B immunoglobulin ....................................1741
Herbal teas................................................................................... 573 Human hepatitis B immunoglobulin for intravenous
Hexamidine diisetionate .................................................. 5.2-3217 administration .........................................................................1741
Hexamidini diisetionas .................................................. 5.2-3217 Human insulin .......................................................................... 1800
Hexetidine.................................................................................. 1721 Human measles immunoglobulin......................................... 1742
Hexetidinum............................................................................. 1721 Human normal immunoglobulin................................... 5.3-3514
Hexobarbital.............................................................................. 1722 Human normal immunoglobulin for intravenous
Hexobarbitalum ....................................................................... 1722 administration ................................................................. 5.3-3516
General Notices (1) apply to all monographs and other texts 3669
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3671
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3673
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3675
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3677
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3679
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3681
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3683
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3685
Index EUROPEAN PHARMACOPOEIA 5.3
Technetii (99mTc) exametazimi solutio iniectabilis ........... 854 Tetanus, diphtheria, pertussis (acellular, component),
Technetii (99mTc) gluconatis solutio iniectabilis................ 856 poliomyelitis (inactivated) and haemophilus type b
Technetii (99mTc) humani albumini solutio iniectabilis .. 856 conjugate vaccine (adsorbed)................................................ 653
Technetii (99mTc) macrosalbi suspensio iniectabilis......... 858 Tetanus, diphtheria, pertussis and poliomyelitis (inactivated)
Technetii (99mTc) medronati solutio iniectabilis................ 859 vaccine (adsorbed)................................................................... 656
Technetii (99mTc) mertiatidi solutio iniectabilis................. 860 Tetanus, diphtheria, pertussis, poliomyelitis (inactivated) and
Technetii (99mTc) microsphaerarum suspensio haemophilus type b conjugate vaccine (adsorbed) .......... 657
iniectabilis ................................................................................ 861 Tetanus immunoglobulin, human ........................................ 1751
Technetii (99mTc) pentetatis solutio iniectabilis................. 862 Tetanus vaccine (adsorbed) ..................................................... 702
Technetii (99mTc) sestamibi solutio iniectabilis.................. 863 Tetanus vaccine (adsorbed), assay of (2.7.8.) ..............5.1-2791
Technetii (99mTc) succimeri solutio iniectabilis................. 865 Tetanus vaccine for veterinary use ........................................ 795
Technetium (99mTc) colloidal rhenium sulphide injection Tetracaine hydrochloride .......................................................2546
..................................................................................................... 851 Tetracaini hydrochloridum ..................................................2546
Technetium (99mTc) colloidal sulphur injection ................... 852 Tetracosactide...........................................................................2547
Technetium (99mTc) colloidal tin injection ............................ 853 Tetracosactidum ......................................................................2547
Technetium (99mTc) etifenin injection .................................... 853 Tetracycline ...............................................................................2549
Technetium (99mTc) exametazime injection .......................... 854 Tetracycline hydrochloride .................................................... 2551
Technetium (99mTc) gluconate injection ................................ 856 Tetracyclini hydrochloridum ............................................... 2551
Technetium (99mTc) human albumin injection ..................... 856 Tetracyclinum ..........................................................................2549
Technetium (99mTc) macrosalb injection................................ 858 Tetrazepam ................................................................................2552
Technetium (99mTc) medronate injection............................... 859 Tetrazepamum .........................................................................2552
Technetium (99mTc) mertiatide injection ............................... 860 Tetryzoline hydrochloride...............................................5.1-3020
Technetium (99mTc) microspheres injection.......................... 861 Tetryzolini hydrochloridum..........................................5.1-3020
Technetium (99mTc) pentetate injection................................. 862 Thallosi (201Tl) chloridi solutio iniectabilis......................... 867
Technetium (99mTc) sestamibi injection ................................. 863 Thallous (201Tl) chloride injection........................................... 867
Technetium (99mTc) succimer injection.................................. 865 Theobromine.............................................................................2554
Technetium (99mTc) tin pyrophosphate injection................. 865 Theobrominum ........................................................................2554
Temazepam................................................................................2535 Theophylline .............................................................................2554
Temazepamum ........................................................................2535 Theophylline-ethylenediamine ..............................................2557
Tenosynovitis avian viral vaccine (live) ................................. 729 Theophylline-ethylenediamine hydrate ...............................2557
Tenoxicam..................................................................................2537 Theophylline monohydrate....................................................2555
Tenoxicamum ..........................................................................2537 Theophyllinum.........................................................................2554
Terbinafine hydrochloride...............................................5.3-3627 Theophyllinum et ethylenediaminum ...............................2557
Terbinafini hydrochloridum .........................................5.3-3627 Theophyllinum et ethylenediaminum hydricum............2557
Terbutaline sulphate ...............................................................2538 Theophyllinum monohydricum ..........................................2555
Terbutalini sulfas ....................................................................2538 Thermal analysis (2.2.34.). ......................................................... 52
Terconazole ...............................................................................2539 Thermogravimetry (2.2.34.)....................................................... 52
Terconazolum ..........................................................................2539 Thiamazole ................................................................................2558
Terebinthini aetheroleum ab pinum pinastrum .............2645 Thiamazolum ...........................................................................2558
Terfenadine................................................................................2540 Thiamine hydrochloride .........................................................2559
Terfenadinum...........................................................................2540 Thiamine nitrate....................................................................... 2561
Terminology used in monographs on vaccines (5.2.1.) ..... 453 Thiamini hydrochloridum ....................................................2559
tert-Butylamini perindoprilum.....................................5.3-3589 Thiamini nitras........................................................................ 2561
Test for anticomplementary activity of immunoglobulin Thiamphenicol ..........................................................................2562
(2.6.17.)....................................................................................... 170 Thiamphenicolum...................................................................2562
Test for anti-D antibodies in human immunoglobulin for Thin-layer chromatography (2.2.27.).............................5.2-3090
intravenous administration (2.6.26.) ..........................5.3-3348 Thiomersal..........................................................................5.1-3021
Test for deliverable mass or volume of liquid and semi-solid Thiomersalum...................................................................5.1-3021
preparations (2.9.28.).............................................................. 263 Thiopental sodium and sodium carbonate.........................2564
Test for extractable volume of parenteral preparations Thiopentalum natricum et natrii carbonas .....................2564
(2.9.17.)..............................................................................5.3-3363 Thioridazine ..............................................................................2565
Test for Fc function of immunoglobulin (2.7.9.) ................. 202 Thioridazine hydrochloride ...................................................2566
Test for methanol and 2-propanol (2.9.11.) .................5.3-3362 Thioridazini hydrochloridum..............................................2566
Test for neurovirulence of live virus vaccines (2.6.18.) ..... 172 Thioridazinum.........................................................................2565
Test for neurovirulence of poliomyelitis vaccine (oral) Three-lobed sage leaf...............................................................2390
(2.6.19.) ...................................................................................... 172 Threonine...................................................................................2566
Testosterone..............................................................................2542 Threoninum..............................................................................2566
Testosterone enantate.............................................................2544 Thyme .........................................................................................2567
Testosterone propionate.........................................................2545 Thyme oil ..................................................................................2569
Testosteroni enantas ..............................................................2544 Thyme, wild ............................................................................... 2701
Testosteroni propionas ..........................................................2545 Thymi aetheroleum ................................................................2569
Testosteronum..........................................................................2542 Thymi herba .............................................................................2567
Tests for extraneous agents in viral vaccines for human use Thymol........................................................................................2570
(2.6.16.) ...................................................................................... 169 Thymolum .................................................................................2570
Tetanus antitoxin for human use ........................................... 805 Tiabendazole .............................................................................2570
Tetanus antitoxin for veterinary use.............................5.1-2868 Tiabendazolum ........................................................................2570
Tetanus, diphtheria and hepatitis B (rDNA) vaccine Tiamulin for veterinary use ...................................................2571
(adsorbed).................................................................................. 641 Tiamulin hydrogen fumarate for veterinary use ...............2573
Tiamulini hydrogenofumaras ad usum veterinarium ..2573
General Notices (1) apply to all monographs and other texts 3687
Index EUROPEAN PHARMACOPOEIA 5.3
General Notices (1) apply to all monographs and other texts 3689
Index EUROPEAN PHARMACOPOEIA 5.3
Vaccinum diphtheriae, tetani et pertussis adsorbatum .. 643 Vaccinum morbi Aujeszkyi ad suem vivum cryodesiccatum
Vaccinum diphtheriae, tetani et pertussis sine cellulis ex ad usum parenterale ...............................................................717
elementis praeparatum adsorbatum.................................. 642 Vaccinum morbi Carrei vivum cryodesiccatum ad canem
Vaccinum diphtheriae, tetani, pertussis et poliomyelitidis ..................................................................................................... 740
inactivatum adsorbatum....................................................... 656 Vaccinum morbi Carrei vivum cryodesiccatum ad
Vaccinum diphtheriae, tetani, pertussis, poliomyelitidis mustelidas................................................................................. 751
inactivatum et haemophili stirpe b coniugatum Vaccinum morbillorum, parotitidis et rubellae vivum.... 678
adsorbatum............................................................................... 657 Vaccinum morbillorum vivum............................................... 679
Vaccinum diphtheriae, tetani, pertussis sine cellulis ex Vaccinum morbi Marek vivum .............................................. 774
elementis praeparatum et haemophili stirpe b coniugatum Vaccinum morbi partus diminutionis MCMLXXVI
adsorbatum............................................................................... 645 inactivatum ad pullum .......................................................... 753
Vaccinum diphtheriae, tetani, pertussis sine cellulis Vaccinum myxomatosidis vivum ad cuniculum ............... 775
ex elementis praeparatum et hepatitidis B (ADNr) Vaccinum panleucopeniae felinae infectivae
adsorbatum............................................................................... 647 inactivatum .............................................................................. 759
Vaccinum diphtheriae, tetani, pertussis sine cellulis ex Vaccinum panleucopeniae felinae infectivae vivum....... 760
elementis praeparatum et poliomyelitidis inactivatum Vaccinum parainfluenzae viri bovini vivum
adsorbatum............................................................................... 648 cryodesiccatum ....................................................................... 732
Vaccinum diphtheriae, tetani, pertussis sine cellulis Vaccinum parainfluenzae viri canini vivum..................... 742
ex elementis praeparatum, hepatitidis B (ADNr), Vaccinum paramyxoviris 3 aviarii inactivatum ............... 728
poliomyelitidis inactivatum et haemophili stirpe b Vaccinum parotitidis vivum ................................................... 684
coniugatum adsorbatum....................................................... 650 Vaccinum parvovirosis caninae inactivatum .................... 743
Vaccinum diphtheriae, tetani, pertussis sine cellulis ex Vaccinum parvovirosis caninae vivum ............................... 744
elementis praeparatum poliomyelitidis inactivatum et Vaccinum parvovirosis inactivatum ad suem ................... 787
haemophili stirpe b coniugatum adsorbatum................. 653 Vaccinum pasteurellae inactivatum ad ovem.................... 783
Vaccinum encephalitidis ixodibus advectae Vaccinum pertussis................................................................... 685
inactivatum ..................................................................... 5.3-3414 Vaccinum pertussis adsorbatum ........................................... 690
Vaccinum encephalomyelitidis infectivae aviariae Vaccinum pertussis sine cellulis copurificatum
vivum.......................................................................................... 725 adsorbatum............................................................................... 688
Vaccinum erysipelatis suillae inactivatum ........................ 793 Vaccinum pertussis sine cellulis ex elementis praeparatum
Vaccinum febris flavae vivum.......................................5.1-2852 adsorbatum......................................................................5.3-3407
Vaccinum febris typhoidi ........................................................ 707 Vaccinum pestis anatis vivum ......................................5.3-3419
Vaccinum febris typhoidi cryodesiccatum ......................... 707 Vaccinum pestis classicae suillae vivum
Vaccinum febris typhoidis polysaccharidicum ................. 705 cryodesiccatum ....................................................................... 793
Vaccinum febris typhoidis vivum perorale (stirpe Vaccinum pneumococcale polysaccharidicum................. 691
Ty 21a) ....................................................................................... 708 Vaccinum pneumococcale polysaccharidicum coniugatum
Vaccinum furunculosidis ad salmonidas inactivatum cum adsorbatum......................................................................5.1-2851
adiuvatione oleosa ad iniectionem.................................... 767 Vaccinum poliomyelitidis inactivatum ............................... 692
Vaccinum haemophili stirpe b coniugatum....................... 662 Vaccinum poliomyelitidis perorale ............................. 5.3-3410
Vaccinum hepatitidis A inactivatum adsorbatum ............ 665 Vaccinum pseudopestis aviariae inactivatum................... 779
Vaccinum hepatitidis A inactivatum et hepatitidis B (ADNr) Vaccinum pseudopestis aviariae vivum.............................. 781
adsorbatum............................................................................... 664 Vaccinum rabiei ex cellulis ad usum humanum .............. 699
Vaccinum hepatitidis A inactivatum virosomale.............. 667 Vaccinum rabiei inactivatum ad usum veterinarium ..... 790
Vaccinum hepatitidis B (ADNr)............................................. 670 Vaccinum rabiei perorale vivum ad vulpem ...................... 792
Vaccinum hepatitidis viralis anatis stirpe I vivum .......... 751 Vaccinum rhinitidis atrophicantis ingravescentis suillae
Vaccinum herpesviris equini inactivatum ......................... 754 inactivatum .............................................................................. 788
Vaccinum inactivatum diarrhoeae vituli coronaviro Vaccinum rhinotracheitidis infectivae bovinae vivum
illatae ......................................................................................... 736 cryodesiccatum ....................................................................... 768
Vaccinum inactivatum diarrhoeae vituli rotaviro Vaccinum rhinotracheitidis viralis felinae inactivatum.. 762
illatae ......................................................................................... 737 Vaccinum rhinotracheitidis viralis felinae vivum
Vaccinum influenzae equi inactivatum.............................. 755 cryodesiccatum ....................................................................... 763
Vaccinum influenzae inactivatum ad suem ...................... 785 Vaccinum rubellae vivum ....................................................... 701
Vaccinum influenzae inactivatum ex corticis antigeniis Vaccinum tenosynovitidis viralis aviariae vivum ............ 729
praeparatum....................................................................5.3-3402 Vaccinum tetani adsorbatum ................................................. 702
Vaccinum influenzae inactivatum ex corticis antigeniis Vaccinum tetani ad usum veterinarium ............................. 795
praeparatum virosomale..............................................5.3-3404 Vaccinum tuberculosis (BCG) cryodesiccatum ................. 636
Vaccinum influenzae inactivatum ex viris integris Vaccinum varicellae vivum .................................................... 709
praeparatum....................................................................5.3-3406 Vaccinum variolae gallinaceae vivum ............................... 766
Vaccinum influenzae inactivatum ex virorum fragmentis Vaccinum vibriosidis ad salmonidas inactivatum ........... 797
praeparatum....................................................................5.3-3401 Vaccinum vibriosidis aquae frigidae inactivatum ad
Vaccinum laryngotracheitidis infectivae aviariae salmonidas................................................................................ 796
vivum.......................................................................................... 727 Vaccinum viri syncytialis meatus spiritus bovini vivum
Vaccinum leptospirosis bovinae inactivatum.................... 730 cryodesiccatum ....................................................................... 733
Vaccinum leptospirosis caninae inactivatum ................... 740 Vaginal capsules ................................................................5.2-3153
Vaccinum leucosis felinae inactivatum................................761 Vaginal foams.....................................................................5.2-3154
Vaccinum mannheimiae inactivatum ad bovidas ............ 771 Vaginalia ............................................................................5.2-3152
Vaccinum mannheimiae inactivatum ad ovem ................ 772 Vaginal preparations ........................................................5.2-3152
Vaccinum meningococcale classis C coniugatum ........... 680 Vaginal preparations, semi-solid ....................................5.2-3153
Vaccinum meningococcale polysaccharidicum................ 682 Vaginal solutions and suspensions, tablets for...........5.2-3153
Vaccinum morbi Aujeszkyi ad suem inactivatum ............ 715 Vaginal solutions, emulsions and suspensions...........5.2-3153
General Notices (1) apply to all monographs and other texts 3691
Index EUROPEAN PHARMACOPOEIA 5.3